Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic.

Tareq, Abu Montakim; Emran, Talha Bin; Dhama, Kuldeep; Dhawan, Manish; Tallei, Trina Ekawati

Tareq, Abu Montakim; Emran, Talha Bin; Dhama, Kuldeep; Dhawan, Manish; Tallei, Trina Ekawati.

Afiliação

Tareq AM; Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
Emran TB; Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh.
Dhama K; Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Dhawan M; Department of Microbiology, Punjab Agricultural University, Ludhiana, India.
Tallei TE; The Trafford Group of Colleges, Manchester, UK.

Hum Vaccin Immunother ; 17(11): 4126-4127, 2021 11 02.

Article em En | MEDLINE | ID: mdl-34473593

Assuntos

COVID-19; Vacinas; Humanos; Pandemias/prevenção & controle; SARS-CoV-2

Palavras-chave

COVID-19; SARS-CoV-2; delta variant (B.1.617.2); second wave; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google